JiangSu WuZhong Pharmaceutical Development Co., Ltd.

Shanghai Stock Exchange 600200.SS

JiangSu WuZhong Pharmaceutical Development Co., Ltd. Dividend Per Share for the year ending December 31, 2023: USD 0.01

JiangSu WuZhong Pharmaceutical Development Co., Ltd. Dividend Per Share is USD 0.01 for the year ending December 31, 2023, a -8.28% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

JiangSu WuZhong Pharmaceutical Development Co., Ltd. Dividend Per Share for the year ending December 31, 2022 was USD 0.01, a 3.76% change year over year.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Dividend Per Share for the year ending December 31, 2021 was USD 0.01, a 2.31% change year over year.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Dividend Per Share for the year ending December 31, 2020 was USD 0.01, a 29.87% change year over year.
JiangSu WuZhong Pharmaceutical Development Co., Ltd. Dividend Per Share for the year ending December 31, 2019 was USD 0.01, a -32.05% change year over year.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

Shanghai Stock Exchange: 600200.SS

JiangSu WuZhong Pharmaceutical Development Co., Ltd.

CEO	Mr. Qunshan Qian
IPO Date	April 1, 1999
Location	China
Headquarters	988 Dongfang Avenue
Employees	1,050
Sector	Real Estate
Industries Health Care REITs Industrial REITs

Description

JiangSu WuZhong Pharmaceutical Development Co., Ltd., together with its subsidiaries, engages in pharmaceutical, real estate, and chemical businesses in China. It develops, produces, and sells anti-infective, digestive system, cardiovascular, cerebrovascular, antiviral, vitamin, and hemostatic drugs; and immunomodulations, including biopharmaceuticals, chemical drugs, and modern Chinese medicines. The company offers its products in various forms, such as infusion solutions, water and powder injections, capsules, granules, tablets, emulsions, and oral liquids. It also engages in the research, development, production, and sale of dyes and dye intermediates; and the fields of commercial housing and affordable housing development. The company was founded in 1994 and is based in Suzhou, China.

Key trends

Past 5 years